Vanda Pharmaceuticals
VNDA
#8792
Rank
A$0.32 B
Marketcap
A$5.33
Share price
-3.68%
Change (1 day)
-32.69%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): A-$6.79

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$6.97. In 2025 the company made an earnings per share (EPS) of A-$5.62 a decrease over its 2024 EPS that were of A-$0.48.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$6.7920.72%
2025A-$5.621065.63%
2024A-$0.48-710.9%
2023A$0.07899-56.35%
2022A$0.18-80%
2021A$0.90
2019A$3.27334%
2018A$0.75-247.06%
2017A-$0.51-19.05%
2016A-$0.63-55.32%
2015A-$1.42-347.37%
2014A$0.57-156.72%
2013A-$1.01-31.63%
2012A-$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.92-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.58-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.82-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
A-$6.62-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA